Search Results - "Gestaut, Matthew M."

Low Dose Rate Brachytherapy versus Cryotherapy in Low and Intermediate Risk Prostate Cancer by Gestaut, Matthew M., MD, Cai, Wendi, MS, Vyas, Shilpa, MD, Patel, Belur J., MD, MPH, Hasan, Salman A., DO, MunozMaldonado, Yolanda, PhD, Deb, Niloyjyoti, MD, Swanson, Gregory, MD

“…Abstract Purpose Cryotherapy and brachytherapy are definitive local treatment options for low- to intermediate-risk prostate cancer. There are both prospective…”
Get full text

Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival by Gestaut, Matthew M, Antoon, James W, Burow, Matthew E, Beckman, Barbara S

“…Endogenous sphingolipid signaling has been shown to play an important role in prostate cancer endocrine resistance. The novel SphK2 inhibitor, ABC294640, was…”
Get more information

Single fraction spine stereotactic ablative body radiotherapy with volumetric modulated arc therapy by Gestaut, Matthew M., Thawani, Nitika, Kim, Sangroh, Gutti, Veera R., Jhavar, Sameer, Deb, Niloyjyoti, Morrow, Andrew, Ward, Russell A., Huang, Jason H., Patel, Mehul

“…This study investigated a single institution’s experience with volumetric modulated arc therapy (VMAT) directed stereotactic ablative body radiotherapy (SABR)…”
Get full text

Long term clinical toxicity of radiation therapy in prostate cancer patients with Inflammatory Bowel Disease by Gestaut, Matthew M, Swanson, Gregory P

“…Abstract Aim The study's aim was to examine the clinical impact of radiation therapy (RT) on GI toxicity in Inflammatory Bowel Disease (IBD) patients…”
Get full text

Prostate Cancer in Patients With High Prostate-Specific Antigen Levels but Otherwise Very-Low-Risk Disease Behaves Like Prostate Cancer in High-Risk Patients by Gestaut, Matthew M, Pruszynski, Jessica E, Swanson, Gregory P

“…Micro-Abstract A review was conducted of divergent-risk prostate cancer patients treated with radiation. These patients exhibited a low-volume, low-risk…”
Get full text

Design, Synthesis, and Biological Activity of a Family of Novel Ceramide Analogues in Chemoresistant Breast Cancer Cells by Antoon, James W., Liu, Jiawang, Gestaut, Matthew M., Burow, Matthew E., Beckman, Barbara S., Foroozesh, Maryam

“…Resistance to chemotherapy and endocrine therapy is a major cause of breast cancer treatment failure. We have synthesized six novel analogues using C8-ceramide…”
Get full text

To B(iopsy) or not to B(iopsy) by Gestaut, Matthew M, Strober, Edana D, Jhavar, Sameer G, Patel, Mehul K

“…Often in metastatic disease, biopsy confirmation of suspicious central nervous system (CNS) lesions is not mandated according to the American College of…”
Get full text

Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics by Antoon, James W, Liu, Jiawang, Ponnapakkam, Adharsh P, Gestaut, Matthew M, Foroozesh, Maryam, Beckman, Barbara S

“…Purpose Resistance to endocrine and chemotherapies remains the primary cause of breast cancer treatment failure. We have synthesized four novel d-erythro…”
Get full text

Abstract 1031: Sphingolipid metabolism as a therapeutic target in chemotherapy resistant and hormone therapy resistant breast cancer by Gestaut, Matthew M., Antoon, James W., Ponnapakam, Adharsh P., J, Liu, Burow, Matthew E., Foroozesh, Maryam, Beckman, Barbara S.

“…Abstract Endocrine- and chemo-resistance are major causes for failure of treatment in recurrent breast cancer. Normal apoptotic pathways targeted by…”
Get full text

Abstract 2537: The novel sphingosine kinase inhibitor ABC294640 blocks survival and tumorigenesis in chemo- And endocrine resistant breast cancer by Antoon, James W., White, Martin D., Gestaut, Matthew M., Slaughter, Evelyn M., Elliott, Steven, Driver, Jennifer L., Khalili, Hafez S., Smith, Charles D., Burow, Matthew E., Beckman, Barbara S.

“…Abstract Resistance to chemotherapy is a major cause of breast cancer treatment failure today. The sphingolipid metabolizing enzyme sphingosine kinase converts…”
Get full text

To B(iopsy) or not to B(iopsy) by Gestaut, Matthew M, Strober, Edana D, Jhavar, Sameer G, Patel, Mehul K

“…Often in metastatic disease, biopsy confirmation of suspicious central nervous system (CNS) lesions is not mandated according to the American College of…”
Get full text